Abstract
Serum AMH levels are routinely used to predict an individual’s response to controlled ovarian stimulation. The association between AMH and live birth is controversial, however, particularly in older women undergoing treatment with in vitro fertilization (IVF). Previous studies were limited by the exclusion of cycles with preimplantation genetic testing (PGT-A) and frozen embryo transfer (1, 2). Among older women, those with higher AMH may be more likely to achieve blastocysts for biopsy or cryopreservation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
